Please sign in to follow a disease.

Hyperalphalipoproteinemia

MONDO:0015903

An autosomal dominant genetic condition caused by mutation(s) in the CETP gene, encoding cholesteryl ester transfer protein. Affected individuals may have increased longevity due to decreased risk of coronary heart disease.

Also known as: HALP1

11 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Sub-types

Cholesterol-ester transfer protein deficiency (0) Hyperlipidemia due to hepatic triglyceride lipase deficiency (0)

Broader categories

Disease (618) Hyperlipidemia (264) Metabolic disease (215) Human disease (14) Hyperlipoproteinemia (7) Disease by developmental or physiological process (0)

Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Study reveals HPV vaccine gaps in teens with chronic illness

Knowledge-focused Completed

This study looked at how many girls and young women aged 11 to 20 with chronic diseases (like diabetes or immune conditions) got the HPV vaccine, compared to those without chronic illness. Researchers reviewed records of 223 participants from a hospital in France. The goal was to…

Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused

Last updated Jun 27, 2026 07:59 UTC

Hyperalphalipoproteinemia

Sub-types

Broader categories

Study reveals HPV vaccine gaps in teens with chronic illness